MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
ARTV — Artiva Biotherapeutics, Inc. Common Stock
NasdaqArtiva Biotherapeutics, Inc. Common Stock
$6.83
+0.04(+0.59%)
- O
- 6.89
- H
- 7.00
- L
- 6.74
- V
- 587.44K
⏱️ End-of-day dataAs of Oct 2, 2026
ARTV — Latest News & Headlines
6 StoriesArtiva Biotherapeutics, Inc. (ARTV) Stock Price, News, Quote & History - Yahoo! Finance Canada
Artiva Biotherapeutics, Inc. (ARTV) Stock Price, News, Quote & History Yahoo! Finance Canada
A cell treatment and a drug depleted antibody-making immune cells in 60 people with rheumatic diseases - stocktitan.net
A cell treatment and a drug depleted antibody-making immune cells in 60 people with rheumatic diseases stocktitan.net
The Technical Signals Behind (ARTV) That Institutions Follow - Stock Traders Daily
The Technical Signals Behind (ARTV) That Institutions Follow Stock Traders Daily
H.C. Wainwright reiterates Buy on Artiva stock, $35 target By Investing.com - Investing.com Nigeria
H.C. Wainwright reiterates Buy on Artiva stock, $35 target By Investing.com Investing.com Nigeria
Cantor Fitzgerald reiterates Artiva Biotherapeutics stock rating By Investing.com - Investing.com UK
Cantor Fitzgerald reiterates Artiva Biotherapeutics stock rating By Investing.com Investing.com UK
Artiva to present AlloNK data at ACR Convergence 2026 By Investing.com - Investing.com UK
Artiva to present AlloNK data at ACR Convergence 2026 By Investing.com Investing.com UK